In other words published studies on chemerin concentration in type 2 diabetic subjects are inconsistent possibly due to the heterogenous nature of type 2 diabetes, possible impact of diabetes drugs, and disease duration. This evidence concerns the gene RARRES2 and diabetes mellitus.